E. Lynne Kelley
Keine laufenden Positionen mehr
Profil
E.
Lynne Kelley is currently the Chief Executive & Medical Officer at Signalexis, Inc. Previously, she held positions as Medical Director at Kimberly-Clark Corp.
and Boston Scientific Corp., Assistant Professor at Yale University, and Vice President-Medical Affairs at Becton, Dickinson & Co. She also served as Chief Medical Officer at Histogenics Corp., Senseonics Holdings, Inc., and X4 Pharmaceuticals, Inc. Kelley received her undergraduate degree from Boston University and her doctorate from Dartmouth Medical School.
Aktive Positionen von E. Lynne Kelley
| Unternehmen | Position | Beginn |
|---|
Ehemalige bekannte Positionen von E. Lynne Kelley
| Unternehmen | Position | Ende |
|---|---|---|
| X4 PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 03.04.2020 |
| OCUGEN, INC. | Technik-/Wissenschafts-/F&E-Leiter | 23.01.2019 |
| BECTON, DICKINSON AND COMPANY | Corporate Officer/Principal | 01.01.2016 |
| KIMBERLY-CLARK CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2010 |
| BOSTON SCIENTIFIC CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2007 |
Ausbildung von E. Lynne Kelley
| Boston University | Undergraduate Degree |
| Dartmouth Medical School | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 5 |
|---|---|
| SENSEONICS HOLDINGS, INC. | Electronic Technology |
| BECTON, DICKINSON AND COMPANY | Health Technology |
| KIMBERLY-CLARK CORPORATION | Consumer Non-Durables |
| BOSTON SCIENTIFIC CORPORATION | Health Technology |
| X4 PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Histogenics Corp.
 Histogenics Corp. BiotechnologyHealth Technology Histogenics Corp. engages in the development, marketing, and commercialization of restorative cell therapies. Its regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives, and growth factors to provide solutions that can be utilized individually and in concert to treat musculoskeletal-related conditions. The company was founded on June 28, 2000 and is headquartered in Waltham, MA. | Health Technology |
